EUVIMEDEUVIMED entdecken
Open Access

Medium-Ring Keto Bislactams with Antischistosomal Activity

Rongguo Ren, Derek A Leas, Cécile Häberli, Monica Cal, Gong Chen, Kasiram Katneni, Yuxiang Dong iD, Marcel Kaiser, Jennifer Keiser, Susan A Charman iD, Jonathan L Vennerstrom iD

Journal of Medicinal Chemistry · 24.10.2024 · 67 (20) · 18235-18246

DOI: 10.1021/acs.jmedchem.4c01532 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 08.10.2024. Verfasst von Rongguo Ren und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, Nebraska 986125, United States. Hauptthemen laut MEDLINE: Lactams, Schistosoma mansoni. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We discovered medium-ring keto bislactams as a new antischistosomal chemotype. The ketone functional group and isoindolinone substructure were required for high antischistosomal activity. Aryl substitution with EWG functional groups decreased the chemical stability. These compounds were relatively polar with the measured LogD7.4 values ranging from 320 μM, and had relatively low cytotoxicities with IC50s ranging from 52 to >390 μM. We identified two compounds with IC50 values < 5 μM against ex vivoSchistosoma mansoni (S. mansoni).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LactamsSchistosoma mansoniAnimalsStructure-Activity RelationshipMiceSchistosomicidesHumans

Substanzen

LactamsSchistosomicides

Autor:innen und Institutionen

  • College of Pharmacy, University of Nebraska Medical Center, Nebraska Medical Center, Omaha, Nebraska 986125, United States.
  • Department of Medical Parasitology and Infection Biology, Swiss Tropical Institute, Socinstrasse 57, Basel CH-4002, Switzerland.
  • University of Basel, Basel CH-4003, Switzerland.
  • Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, Victoria 3052, Australia.

ORCID-Profile: Yuxiang Dong, Susan A Charman, Jonathan L Vennerstrom

Förderung

  • NIAID NIH HHS
  • Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Ren, R., Leas, D. A., Häberli, C., Cal, M., Chen, G., Katneni, K., Dong, Y., Kaiser, M., Keiser, J., Charman, S. A., & Vennerstrom, J. L. (2024). Medium-Ring Keto Bislactams with Antischistosomal Activity. Journal of Medicinal Chemistry, 67(20), 18235-18246. https://doi.org/10.1021/acs.jmedchem.4c01532

Vancouver

Ren R, Leas DA, Häberli C, Cal M, Chen G, Katneni K, et al. Medium-Ring Keto Bislactams with Antischistosomal Activity. Journal of Medicinal Chemistry. 2024;67(20):18235-18246. doi:10.1021/acs.jmedchem.4c01532

BibTeX
@article{Ren2024,
  author = {Ren, Rongguo and Leas, Derek A and Häberli, Cécile and Cal, Monica and Chen, Gong and Katneni, Kasiram and Dong, Yuxiang and Kaiser, Marcel and Keiser, Jennifer and Charman, Susan A and Vennerstrom, Jonathan L},
  title = {Medium-Ring Keto Bislactams with Antischistosomal Activity},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  volume = {67},
  number = {20},
  pages = {18235--18246},
  doi = {10.1021/acs.jmedchem.4c01532}
}
Kostenlos starten →